Bringing the fundamentals into focus…
Back to Kymera Therapeutics, Inc.
How Kymera Therapeutics, Inc. stacks up
KYMR · against 160 other Healthcare companies of similar size
Valuation
44/ 100
Below the middle of the pack.
Ranked #105 of 161 · scores higher than 33% of peers
Bars: peers in each 10-point band of the valuation score27 peers with a valuation score of 40–49, including KYMR · Click a bar to see the companies
Why valuation scores 44?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -3.4% vs peer median 4.0%
- lower earnings for the price paid: weaker than 68% of peers. Earnings yield: 3.1% vs peer median 1.5%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -2.3% vs peer median 0.0%
Metric by metric
Position: dot = KYMR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | KYMR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 160 reported | -2.6% | 2.5% | 15% | 30% | |
| EBITDA yieldHigher is better · 160 reported | -3.4% | 4.7% | 10% | 50% | |
| Free cash flow yieldHigher is better · 96 reported | -2.3% | 2.2% | 23% | 20% | |
| Book yieldHigher is better · 159 reported | 14.3% | 18.8% | 35% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around KYMR| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 2 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 3 | 10.4B USD | 96 | 64 | |
| 4 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 5 | 11.6B USD | 94 | 58 | |
| 100 | 11.4B USD | 46 | 64 | |
| 102 | 1.21T INR (≈$14.6B) | 45 | 55 | |
| 102 | 27.5B NZD (≈$16.5B) | 45 | 69 | |
| 102 | 5.3B USD | 45 | 50 | |
| 105 | 10.5B USD | 44 | 56 | |
| 105 | 871.6B INR (≈$10.5B) | 44 | 66 | |
| 105 | 5.7B USD | 44 | 38 | |
| 105 | 5.9B USD | 44 | 39 | |
| 109 | 16.9B USD | 43 | 37 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score